Printer Friendly

Browse Prostatic hyperplasia topic

Drug therapy subtopic


1-35 out of 35 article(s)
Title Author Type Date Words
Comparison of Clinical Effectiveness of Deslorelin Acetate and Osaterone Acetate in Dogs with Benign Prostatic Hyperplasia. Nizanski, Wojciech; Ochota, Malgorzata; Fontaine, Christelle; Pasikowska, Joanna Oct 1, 2020 7900
Global Benign Prostatic Hypertrophy Drugs Market Report 2020: Market was Valued at $4.03 Billion in 2018 and is Expected to Grow to $5.65 Billion through 2022. Report Dec 12, 2019 636
Evaluation of anterior segment changes of patients taking alpha1-blockers by ultrasound biomicroscopy in the drug-free period. Acar, Yeliz; Eltutar, Kadir; Zirtiloglu, Sibel Report Jul 1, 2017 3468
Efficiency of sildanefil monotherapy in benign prostatic hyperplasia/Nova opcija medikamentoznog tretmana benigne hiperplazije prostate i simptoma donjeg urinarnog trakta. Grbic, Dragan; Vojinov, Sasa; Jeremic, Dimitrije; Levakov, Ivan; Dozic, Senjin; Sekulic Vuk Report Nov 1, 2016 2752
Mylan unveils generic Avodart Capsules for treating benign prostatic hyperplasia in men in the US. Jun 27, 2016 189
Mylan unveils generic Avodart Capsules for treating benign prostatic hyperplasia in men in the US. Jun 27, 2016 185
Clinical use of low dose Tadalafil in combination with alpha blocker in the management of benign prostatic hyperplasia. Gupta, Manish; Gupta, H.L.; Deen, Shameer; Sadasukhi, T.C. Feb 11, 2016 3050
Cost analysis of fixed-dose combination of dutasteride and tamsulosin compared with concomitant dutasteride and tamsulosin monotherapy in patients with benign prostatic hyperplasia in Canada. Sayani, Amyn; Ismaila, Afisi; Walker, Anna; Posnett, John; Laroche, Bruno; Nickel, J. Curtis; Su, Zh Report Jan 1, 2014 4715
Benign prostat hiperplazisi ile iliskili alt uriner sistem semptomlannin tedavisinde fosfodiesteraz tip-5 inhibitorlerinin rolu / The role of phosphodiesterase type-5 inhibitors in treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia. Umul, Mehmet; Serel, Tekin Ahmet Report Dec 1, 2013 4377
Cost-effectiveness of dutasteride-tamsulosin combination therapy for the treatment of symptomatic benign prostatic hyperplasia: A Canadian model based on the CombAT trial. Ismaila, Afisi; Walker, Anna; Sayani, Amyn; Laroche, Bruno; Nickel, J. Curtis; Posnett, John; Su, Zh Report May 1, 2013 4441
Pills for prostates. Dec 1, 2012 889
Prompt use of medications may slow BPH progression. Brief article Dec 1, 2011 193
For BPH, saw palmetto no better than placebo. Moon, Mary Ann Oct 15, 2011 613
Surgery for benign prostatic hyperplasia offers more relief than drug therapy. May 30, 2010 249
Medications may bolster the prostate cancer arsenal: study findings confirm that drugs for enlarged prostate may reduce prostate cancer risk. Aug 1, 2009 488
Intraprostatic botulinum toxin injections for treatment of benign prostatic hypertrophy relieves symptoms for up to 30 months, physicians in Italy report. Brief article Feb 16, 2009 285
Which pill is right for your enlarged prostate: a variety of medications can help when your swollen prostate causes urinary problems, but not every one may be right for you. Jun 1, 2008 977
Cetrorelix shows promise in BPH. Walsh, Nancy Mar 15, 2008 505
Cetrorelix shows promise in prostatic hyperplasia. Walsh, Nancy Mar 1, 2008 695
Lycopene inhibits progression of benign prostate hyperplasia. Boylan, Matthew Mar 1, 2008 563
Relevance of anti-reactive oxygen species activity to anti-inflammatory activity of components of Eviprostat[R], a phytotherapeutic agent for benign prostatic hyperplasia. Oka, Michiko; Tachibana, Masaki; Noda, Kumiko; Inoue, Naoki; Tanaka, Mitsushi; Kuwabara, Kenji Aug 1, 2007 4777
A comprehensive review on the stinging nettle effect and efficacy profiles. Part II: Urticae radix. Chrubasik, Julia E.; Roufogalis, Basil D.; Wagner, Hildebert; Chrubasik, Sigrun Aug 1, 2007 8296
Suppliers keep pipeline flowing; medications for diverse conditions win FDA approval. Brief article Jun 25, 2007 284
Prevent prostate enlargement with aspirin. Brief article Nov 1, 2006 112
Alpha blockers. Aug 1, 2006 425
Alfuzosin slows clinical progression of BPH. MacNeil, Jane Salodof Clinical report Jun 1, 2006 852
Saw palmetto ineffective vs. prostatic hyperplasia. Tanzola, Melinda Clinical report Jun 1, 2006 348
PDE-5 inhibitors may relieve male urinary symptoms: agents tested alone and with alfuzosin. MacNeil, Jane Salodof May 1, 2006 819
Label change ordered for prostate drug. Brief article Feb 1, 2006 169
Less prostate cancer in men given dutasteride for BPH. Nov 1, 2004 372
Tamsulosin may benefit some men with prostatic hypertrophy. Brief Article Oct 15, 2004 293
Tamsulosin may benefit nonresponders to saw palmetto BPH therapy; postmarketing data. Brief Article Jul 1, 2004 294
Drug combo tackles prostatic hyperplasia: finasteride, doxazosin. Splete, Heidi Jan 15, 2004 306
New erectile dysfunction drug passes QT test: changes in heart rates. Mechcatie, Elizabeth Sep 1, 2003 798

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |